These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Nurden AT, Viallard JF, Nurden P. Lancet; 2009 May 02; 373(9674):1562-9. PubMed ID: 19324405 [Abstract] [Full Text] [Related]
6. AMG 531 for chronic ITP. Prasad K. N Engl J Med; 2007 Jan 18; 356(3):307-8; author reply 308. PubMed ID: 17240535 [No Abstract] [Full Text] [Related]
7. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Thromb Haemost; 2008 Jan 18; 99(1):4-13. PubMed ID: 18217129 [Abstract] [Full Text] [Related]
8. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura. Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ, Christal J, Chen CF, Nichol JL. Br J Haematol; 2006 Nov 18; 135(4):547-53. PubMed ID: 17061981 [Abstract] [Full Text] [Related]
12. The road to romiplostim approval and beyond. Lyman GH. Oncology (Williston Park); 2009 Jul 18; 23(8):709-10, 715. PubMed ID: 19711586 [No Abstract] [Full Text] [Related]
13. [Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital]. Riu Viladoms G, Creus Baró N, Estefanell Tejero A, Ribas Sala J. Farm Hosp; 2012 Jul 18; 36(5):434-7. PubMed ID: 22871365 [No Abstract] [Full Text] [Related]
14. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy. Mitsuhashi K, Ishiyama M, Imai Y, Shiseki M, Mori N, Teramura M, Seshimo A, Motoji T. Br J Haematol; 2012 Sep 18; 158(6):798-800. PubMed ID: 22758388 [No Abstract] [Full Text] [Related]
15. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. N Engl J Med; 2006 Oct 19; 355(16):1672-81. PubMed ID: 17050891 [Abstract] [Full Text] [Related]
16. AMG 531 for chronic ITP. Tauro S. N Engl J Med; 2007 Jan 18; 356(3):307; author reply 308. PubMed ID: 17229962 [No Abstract] [Full Text] [Related]
17. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura. Fozza C, Pardini S, Marras T, Longu F, Isoni A, Contini S, Longinotti M. Ann Hematol; 2014 May 18; 93(5):899-900. PubMed ID: 24081576 [No Abstract] [Full Text] [Related]
19. The promise of thrombopoietins in the treatment of ITP. Kuter DJ. Clin Adv Hematol Oncol; 2005 Jun 07; 3(6):464-6. PubMed ID: 16167023 [No Abstract] [Full Text] [Related]
20. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review. Panzer S. Vox Sang; 2008 Jan 07; 94(1):1-5. PubMed ID: 17973895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]